{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-003438","form_type":"8-K","ticker":"USAQ","cik":"0000856984","company_name":"QHSLab, Inc.","filed_at":"2026-01-23T23:59:59+00:00","discovered_at":"2026-05-14T18:02:37.832927+00:00","generated_at":"2026-05-16T08:37:48.250028+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"QHSLab repurchases $470K promissory note with 1.57M shares, extinguishing related-party debt","bullets":["Repurchased and cancelled promissory note held by MedScience; outstanding principal and interest $470,529 as of Dec 31, 2025.","Issued 1,568,432 shares of common stock as consideration; shares issued in private transaction exempt from registration.","CEO Troy Grogan is minority shareholder of MedScience; received no personal distribution from transaction.","Company states repurchase simplifies capital structure and eliminates related-party debt obligation."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-003438","json":"https://secwatch.observer/filing/0001493152-26-003438.json","markdown":"https://secwatch.observer/filing/0001493152-26-003438.md","text":"https://secwatch.observer/filing/0001493152-26-003438.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/856984/000149315226003438/0001493152-26-003438-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/856984/000149315226003438/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T08:37:48.250028+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4a94f2f2a3a965adec0d8da15d0a3e7baf223803","claim":"QHSLab, Inc. terminated Repurchase Agreement with MedScience Research Group, Inc..","evidence_excerpt":"QHSLab, Inc. (the “Company”) consummated a Note Repurchase Agreement (the “Repurchase Agreement”) with MedScience Research Group, Inc., a Florida corporation (“MedScience”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/856984/000149315226003438/0001493152-26-003438-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"termination"},{"label":"Counterparty","value":"MedScience Research Group, Inc."}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}